Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Injury ; 55(8): 111698, 2024 Jun 21.
Article in English | MEDLINE | ID: mdl-38959675

ABSTRACT

INTRODUCTION: Case volumes of trauma centers and surgeons influence clinical outcomes following orthopaedic trauma surgery. This study quantifies surgical volume benchmarks for Orthopaedic Trauma Association (OTA)-accredited fellowship training in the United States. METHODS: This was a retrospective cross-sectional study of orthopaedic trauma fellows graduating between 2018 and 2019 to 2022-2023. Case volume percentiles were calculated across categories and variability defined as the fold-difference between 90th and 10th percentiles. Temporal trends were assessed with linear regression. RESULTS: 446 orthopaedic trauma fellows were included in this study. Mean reported case volume increased from 898 ± 245 in 2018-2019 to 974 ± 329 in 2022-2023 (P = 0.066). Mean case volume was 924 over the study period and mostly consisted of other (418 cases, 45 %), subtrochanteric/intertrochanteric femoral neck (84 cases, 9 %), open fracture debridement (72 cases, 8 %), pelvic ring disruption / fracture (55 cases, 6 %), acetabular fracture (41 cases, 4 %), tibial shaft fracture (39 cases, 4 %), and femoral shaft fracture (38 cases, 4 %) cases. Overall variability in total reported case volume was 2.0. Variability was greatest in distal radius fracture (14.8), amputation (9.5), fasciotomy (8.0), and proximal humerus repair (5.0). CONCLUSION: Graduates from OTA-accredited fellowship training perform 924 cases on average, which exceeds the current minimum requirement of 600 cases. Case volume benchmarks can assist trainees and faculty align training goals with fellowship program strengths. More research is needed to determine evidence-based case minimum requirements for core competency training in orthopaedic trauma surgery.

2.
J Am Acad Orthop Surg ; 32(5): e214-e218, 2024 Mar 01.
Article in English | MEDLINE | ID: mdl-38175999

ABSTRACT

Major extremity fractures are serious limb injuries often including notable soft-tissue injury with possible injuries to the head, chest, or abdomen. High-energy traumatic fractures carry a high risk of surgical site infections even with use of systemic antibiotics and techniques in risk reduction. The American Academy of Orthopaedic Surgeons released a clinical practice guideline in 2023 based on current literature on the prevention of surgical site infections after major extremity trauma. The case presented in this article is an example to demonstrate the clinical application of these guidelines.


Subject(s)
Fractures, Bone , Surgical Wound Infection , Humans , Anti-Bacterial Agents/therapeutic use , Extremities , Fractures, Bone/surgery , Orthopedic Surgeons , Surgical Wound Infection/etiology , Surgical Wound Infection/prevention & control , United States , Practice Guidelines as Topic
4.
Injury ; 54(10): 110985, 2023 Oct.
Article in English | MEDLINE | ID: mdl-37599192

ABSTRACT

OBJECTIVE: Over 2 million people in the United States sustain fractures related to osteoporosis annually, but only 20% of these patients receive treatment for their osteoporosis. The purpose of this study was to evaluate the effects of a fragility fracture liaison within the orthopedic department on treatment and follow up for osteoporosis. DESIGN: Retrospective cohort study SETTING: University Level I Trauma center PARTICIPANTS: 112 patients treated under the aegis of an interdepartmental fracture liaison and 208 patients treated following the introduction of an orthopedic fragility fracture liaison at a single institution. INTERVENTION: Transition from referral to interdepartmental fracture liaison to intradepartmental orthopedic fragility fracture liaison for fragility fractures. MAIN OUTCOME MEASURES: Outcomes evaluated included demographics, fracture type, DEXA scan results, follow up and treatment plan, and subsequent fracture. RESULTS: The mean age at time of fracture was 75 years, and the mean BMI was 27. The most common fracture types were femoral neck fractures (29%), pertrochanteric fractures (30%) and femur fractures (8%). There was a statistically significant increase in adherence to follow up and treatment after the introduction of an orthopaedic fragility fracture liaison. CONCLUSIONS: The introduction of an intradepartmental fragility fracture liaison significantly increases osteoporosis follow-up and introduces the ability to combine both osteoporosis treatment and postoperative orthopaedic care. The results of this study highlight the utility of incorporating a fragility fracture liaison within the orthopaedic department given the economic burden of fragility fractures and the morbidity associated with these fractures. LEVEL OF EVIDENCE: III cohort study.


Subject(s)
Femoral Fractures , Orthopedics , Osteoporosis , Humans , Cohort Studies , Follow-Up Studies , Retrospective Studies , Osteoporosis/complications , Osteoporosis/drug therapy
5.
JBJS Case Connect ; 10(3): e20.00182, 2020.
Article in English | MEDLINE | ID: mdl-32960020

ABSTRACT

CASE: A 69-year-old woman with a history of breast cancer, on long-term antiresorptive medications, was treated with carbon fiber cephalomedullary nails for bilateral atypical femur fractures. Her thigh pain was presumed to be from metastatic lesions and was treated with radiation without standard imaging. The index procedure was complicated by a left nail fracture. The patient underwent exchange cephalomedullary nail fixation with plate augmentation. At 1 year, the patient was asymptomatic with radiographs demonstrating healing. CONCLUSION: This case highlights the importance of appropriate imaging in all patients with thigh pain on antiresorptive therapy and features an uncommon complication of carbon fiber cephalomedullary nail fixation.


Subject(s)
Bone Density Conservation Agents/adverse effects , Bone Neoplasms/complications , Denosumab/adverse effects , Femoral Fractures/etiology , Postoperative Complications/etiology , Aged , Bone Neoplasms/drug therapy , Bone Neoplasms/secondary , Female , Femoral Fractures/surgery , Fracture Fixation, Internal/adverse effects , Fracture Fixation, Internal/instrumentation , Humans , Postoperative Complications/surgery , Reoperation
6.
J Orthop Trauma ; 32(7): e245-e250, 2018 07.
Article in English | MEDLINE | ID: mdl-29634600

ABSTRACT

OBJECTIVES: To evaluate the incidence of unplanned reoperations after pelvic ring injuries and to develop a risk prediction model. DESIGN: Retrospective review. SETTING: Level I Trauma Center. PATIENTS: The medical records of 913 patients (644 male and 269 female patients; mean age, 39 years; age range, 16-89 years) with unstable pelvic ring fractures operatively treated at our center from 2003 to 2015 were reviewed. INTERVENTION: Multiple logistic regression analysis was conducted to evaluate the relative contribution of associated clinical parameters to unplanned reoperations. A risk prediction model was developed to assess the effects of multiple covariates. MAIN OUTCOME MEASUREMENTS: Unplanned reoperation for infection, fixation failure, heterotopic ossification, or bleeding complication. RESULTS: Unplanned reoperations totaled 137 fractures, with an overall rate of 15% (8% infection, 6% fixation failure, <1% heterotopic ossification, and <1% bleeding complication). Reoperations for infection and fixation failure typically occurred within the first month after the index procedure. Four independent predictors of reoperation were open fractures, combined pelvic ring and acetabular injuries, abdominal visceral injuries, and increasing pelvic fracture grade. No independent association was shown between reoperation and patient, treatment, or other injury factors. CONCLUSIONS: Unplanned reoperations were relatively common. Infection and fixation failure were the most common indications for unplanned reoperations. Factors associated with reoperation are related to severity of pelvic and abdominal visceral injuries. Our findings suggest that these complications might be inherent and in many cases unavoidable despite appropriate current treatment strategies. LEVEL OF EVIDENCE: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.


Subject(s)
Fracture Fixation, Internal/adverse effects , Fracture Healing/physiology , Fractures, Bone/surgery , Pelvic Bones/injuries , Reoperation/statistics & numerical data , Adult , Age Factors , Aged , Aged, 80 and over , Cohort Studies , Female , Fracture Fixation, Internal/methods , Fractures, Bone/diagnostic imaging , Humans , Incidence , Injury Severity Score , Kaplan-Meier Estimate , Logistic Models , Male , Middle Aged , Multivariate Analysis , Postoperative Complications/diagnosis , Postoperative Complications/surgery , Predictive Value of Tests , Reoperation/methods , Retrospective Studies , Risk Assessment , Sex Factors , Trauma Centers , Young Adult
7.
Orthopedics ; 32(8)2009 Aug.
Article in English | MEDLINE | ID: mdl-19708622

ABSTRACT

Postmenopausal women with osteoporosis are commonly treated with the bisphosphonate class of medications, one of the most frequently prescribed medications in the United States. In the past 4 years, reports have been published implying that long-term bisphosphonate therapy could be linked to atraumatic femoral diaphyseal fractures. This article presents a case of a 67-year-old woman who presented with an atraumatic right femur fracture. She had a medical history notable for use of the bisphosphonate alendronate for 16 years before being switched to ibandronate for 1 year before presentation. She had sustained a similar fracture on the contralateral side 3 years previously. This case report, in addition to a review of the literature, shows that use of the bisphosphonate class of medications for an extended period of time may result in an increased susceptibility to atraumatic femoral diaphyseal fractures. Some studies have suggested that the reason may be the mechanism of action of bisphosphonates, resulting in decreased bone turnover and remodeling. Studies have not shown if the entire class of medications produce a similar result, but patients who have been treated with any bisphosphonate for an extended period of time should be considered at risk. In patients who have already sustained a femoral diaphyseal fracture, imaging of the contralateral side should be performed to identify cortical thickening as an early sign of fracture risk. Patients should also be questioned about thigh pain.


Subject(s)
Bone Density Conservation Agents/adverse effects , Diphosphonates/adverse effects , Femoral Fractures/chemically induced , Femoral Fractures/surgery , Fracture Fixation, Internal , Multiple Trauma/chemically induced , Multiple Trauma/surgery , Aged , Bone Density Conservation Agents/therapeutic use , Diphosphonates/therapeutic use , Humans , Longitudinal Studies , Male , Osteoporosis/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL
...